HomeAll ContractsContract
NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE-MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC), COVID-19
Total Committed
$260K
Product or Service Description
Biomedical Applied Research/Exploratory Development R&D
Total Potential Value
$10.5M
Contracting Agency
Effective Date
April 1, 2019
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Cost plus fixed fee
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
EMINENT SERVICES CORPORATION NIAID DIVISION OF ALLERGY, IMMUNOLOGY & TRANSPLANTATION: IMMUNE MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC) April 5, 2021 Exercise An Option $91,235
EMINENT SERVICES CORPORATION NIAID DIVISION OF ALLERGY, IMMUNOLOGY&TRANSPLANTATION: IMMUNE-MEDIATED DISEASES CLINICAL PRODUCTS CENTER (CPC), COVID-19 May 22, 2020 Exercise An Option $169,228
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page